EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility

Lucía Chico-Sordo, Juan A García-Velasco iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312979 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Lucía Chico-Sordo und 1 weiteren Autor:innen. Beteiligte Einrichtung: IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain. Hauptthemen laut MEDLINE: Biomarkers, Infertility, Female, MicroRNAs. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study of microRNAs (miRNAs) has emerged in recent decades as a key approach to understanding the pathophysiology of many diseases, exploring their potential role as biomarkers, and testing their use as future treatments. Not only have neurological, cardiovascular diseases, or cancer benefited from this research but also infertility. Female infertility, as a disease, involves alterations at multiple levels, such as ovarian and uterine alterations. This review compiles the latest studies published in humans that link female disorders that affect fertility with altered miRNA profiles. Studies on ovarian alterations, including diminished ovarian reserve (DOR), poor ovarian response to stimulation (POR), premature ovarian insufficiency (POI), and polycystic ovary syndrome (PCOS), are summarized and classified based on the expression and type of sample analyzed. Regarding uterine disorders, this review highlights upregulated and downregulated miRNAs primarily identified as biomarkers for endometriosis, adenomyosis, decreased endometrial receptivity, and implantation failure. However, despite the large number of studies in this field, the same limitations that reduce reproducibility are often observed. Therefore, at the end of this review, the main limitations of this type of study are described, as well as specific precautions or safety measures that should be considered when handling miRNAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersInfertility, FemaleMicroRNAsFemaleHumansEndometriosisPolycystic Ovary Syndrome

Stichwörter der Autor:innen

infertilitymicroRNAovarian alterationsuterine disorders

Substanzen

BiomarkersMicroRNAs

Autor:innen und Institutionen

  • IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.
  • IVIRMA Global Research Alliance, IVIRMA Madrid, 28023 Madrid, Spain.
  • School of Health Sciences, Medical Specialties and Public Health, Obstetrics and Gynecology Area, Rey Juan Carlos University Alcorcón, 28922 Madrid, Spain.

ORCID-Profile: Juan A García-Velasco

Zitieren

APA

Chico-Sordo, L., & García-Velasco, J. A. (2024). MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312979

Vancouver

Chico-Sordo L, García-Velasco JA. MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312979

BibTeX
@article{ChicoSordo2024,
  author = {Chico-Sordo, Lucía and García-Velasco, Juan A},
  title = {MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312979}
}
Kostenlos starten →